Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?
about
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionMolecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment.BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysisAngiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia.Lack of Association between Glutathione S-Transferase-M1, -T1, and -P1 Polymorphisms and Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients.Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia.Transcriptome analysis in a rat model of L-DOPA-induced dyskinesiaThe nature of relapse in schizophrenia.Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction.No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia PatientsThe styrene metabolite, phenylglyoxylic acid, induces striatal-motor toxicity in the rat: influence of dose escalation/reduction over timeCarvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanismsTardive dyskinesia and essential fatty acids.Tardive dyskinesia: treatment with aripiprazole.Subcortical neuromorphometry in schizophrenia spectrum and bipolar disorders.Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.Crocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanismNo Evidence for Association between Tyrosine Hydroxylase Gene Val81Met Polymorphism and Susceptibility to Tardive Dyskinesia in SchizophreniaTardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials.Utilizing the concept of geste antagoniste for conservative management of oro-mandibular tardive dyskinesia: a case report and mini-review.Resveratrol Protects Against Vacuous Chewing Movements Induced by Chronic Treatment with Fluphenazine.Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Blood lactate levels as a biomarker of antipsychotic side effects in patients with schizophrenia.Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat.Bauhinia forficata prevents vacuous chewing movements induced by haloperidol in rats and has antioxidant potential in vitro.Protective Effect of Leaves of Murraya koenigii on Reserpine-Induced Orofacial Dyskinesia.Protective effect of Morus alba leaves on haloperidol-induced orofacial dyskinesia and oxidative stress.Korean ginseng extract attenuates reserpine-induced orofacial dyskinesia and improves cognitive dysfunction in rats.Gaba transporter SLC6A11 gene polymorphism associated with tardive dyskinesia.Reversal of haloperidol-induced orofacial dyskinesia by quercetin, a bioflavonoid.Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.There is no evidence for an association between the serotonin receptor 3A gene C178T polymorphism and tardive dyskinesia in Korean schizophrenia patients.Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment.Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.Comparative extrapyramidal effects of Rauwolfia vomitoria, chlorpromazine and reserpine in mice.Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients.Magnesium Supplementation Prevents and Reverses Experimentally Induced Movement Disturbances in Rats: Biochemical and Behavioral Parameters.
P2860
Q30386608-62C022B9-127D-4DCC-8106-6F0C1954CE61Q30428213-56E9D1E4-97D5-49B2-820A-2FB9B2550A19Q33566832-4390EE9C-1C0A-4D83-9F88-4157573E1DE1Q33687719-EEAC1D99-8949-4B3A-9765-0A23B3136731Q33935241-6ECB71EF-59B0-421B-A14C-29ADFCC32041Q34383654-DAB1BB72-B4FD-4E81-AFD5-866935A5A503Q34400095-A9F03745-C9C3-41EC-99E0-055630536A6BQ34581127-827FD673-7011-4DA9-A1F0-3983935D3546Q34651191-5865AB55-1516-4359-BF6A-0889920015AFQ34811987-CA3C0857-B30E-4BEE-A43C-AAB59CA5081EQ34950165-2C4AC1BB-4B90-46E4-BD56-D4C85D9B9321Q35044374-D4A62E01-E936-48E9-8BF5-1D97001D8AF9Q36508056-D4D2197D-6E93-4A53-A806-BEBCEF0FFFA2Q36599203-474140B7-C452-4C81-A507-B94575883654Q36661326-952C49C8-EA11-44E0-BF3B-0EBFA2B1799AQ37264543-7864643A-8BF4-4E22-9EB9-22B5423FBEBFQ37416345-44BFCB36-921B-436F-8A4E-4B44DE04A97EQ37484079-4C09AED8-C5AE-44D6-A232-16A66AB4131DQ37707292-49360B4F-D33C-4474-914D-2160CC6649C2Q38032249-EAA85814-5BCD-4575-83DE-CA81ACA2D7DFQ38206130-C5DFC598-C9DF-457A-8579-FA6CC1626927Q38545655-1E0FD545-5402-43AE-8F6A-DAF428B7D2A9Q38570479-C5E2946A-789F-4BCF-A4FF-1D4AFE702303Q38661066-F2BA40C7-BB52-4FDE-825E-7B1164E61C2AQ38911685-C24D9D6E-F358-4B22-8EE6-C659D0F90E39Q41118477-4485C278-04DD-4D51-B575-85F45BD465FCQ42539139-201DC56C-689E-477B-988B-4A436FC10A1FQ42685864-A1A08A48-58F4-4C97-85D8-FF615136B1C0Q42880698-6AF6E2A9-2F49-4B64-B6B4-0B8E80D0847CQ42964570-799A605C-246C-4D5E-801A-C48956675EA1Q42971036-EE6AC7DE-8F61-49CA-A011-F38066E8D524Q44284561-3872B2D8-EB79-4644-8289-47172B292370Q44386044-04D6A5FD-F558-41F0-B4EE-C9A5194DFB53Q44499703-12C7682A-F07E-42F4-AF8C-C600EB8A2883Q44820338-6EE1A59E-69DD-4FAB-90F4-1C30CA57E76FQ45049137-E251145C-FE60-452B-9971-5BC9C633A640Q46244441-8571C207-D900-46F7-82CF-F9AF471E06BBQ46297168-E8162DDB-445A-4DB0-8C5B-8216F2E73942Q46422249-CADBB046-C4F9-4B62-BCE8-C852953037DCQ46771862-47635747-A168-4D16-9414-A56ADC2EF801
P2860
Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Neurotoxicity associated with ...... ations for tardive dyskinesia?
@ast
Neurotoxicity associated with ...... ations for tardive dyskinesia?
@en
type
label
Neurotoxicity associated with ...... ations for tardive dyskinesia?
@ast
Neurotoxicity associated with ...... ations for tardive dyskinesia?
@en
prefLabel
Neurotoxicity associated with ...... ations for tardive dyskinesia?
@ast
Neurotoxicity associated with ...... ations for tardive dyskinesia?
@en
P1476
Neurotoxicity associated with ...... ations for tardive dyskinesia?
@en
P2093
Jørgensen HA
P304
P356
10.1016/S0301-0082(99)00064-7
P577
2000-08-01T00:00:00Z